Consultation Hub
Welcome to the Food Standards Australia New Zealand (FSANZ) Consultation Hub. This hub is a place for you to find and participate in consultations that interest you.
Recent consultations are displayed below or you can search the full list of activities.
Open consultations
A1305 - Alpha-amylase from Bacillus licheniformis (containing the gene for alpha-amylase from the gene variant ANZ105) as a processing aid
FSANZ has assessed an application made by Danisco Australia Pty Ltd to permit the use of enzyme alpha-amylase (EC 3.2.1.1) as a processing aid in starch processing to produce starch hydrolysates and the production of potable alcohol. FSANZ has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the application. Consultation papers The consultation documents and a copy of...
A1332 – Cross-linked polyester resins as an adsorbent processing aid in wine
FSANZ has assessed an application made by amaea Limited to permit the use of molecularly-imprinted polymers or MIPs (a type of cross-linked polyester resin) as an adsorbent processing aid in wine and has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the application. Consultation papers The consultation documents and a copy of the application can be accessed from the ...
M1023 2024 MRL Harmonisation Proposal
FSANZ has prepared a proposal to consider varying maximum residue limits (MRLs) for specific agricultural and veterinary (agvet) chemicals, where residues may occur in or on food commodities. FSANZ has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the proposal. Consultation papers The consultation documents can be accessed from the M1023 webpage on the FSANZ website....
A1339 - 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL from Escherichia coli BL21 for use as nutritive substances in infant formula products
FSANZ has assessed an application made by Chr. Hansen A/S to permit the voluntary use of 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL produced using genetically modified strains of Escherichia coli BL21, alone or in combination, as nutritive substances in infant formula products. FSANZ has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the application. Consultation papers ...
Closed consultations
-
2026-27 Cost Recovery Arrangements
Food Standards Australia New Zealand (FSANZ) reviews its cost recovery arrangements annually. Stakeholders are consulted as part of the review. We welcome your input into the 2026-27 cost recovery review. FSANZ proposes no fee changes for the 2026 – 27 period. Although there was a pay increase as outlined in the Enterprise Agreement and certain costs did rise, these were offset...
Closed 15 February 2026
-
A1340 - 2′-FL from GM Escherichia coli BL21 (gene donor: Akkermansia muciniphila) for use as a nutritive substance in infant formula products
FSANZ has assessed an application made by Suzhou Yixi Biotech Co., Ltd. to permit 2′-fucosyllactose (2′-FL) produced from a new genetically modified (GM) source organism for use as a nutritive substance in infant formula products. This 2′-FL is sourced from Escherichia coli BL21 containing the gene for alpha-1,2-fucosyltransferase from Akkermansia muciniphila. FSANZ has prepared a draft food...
Closed 12 February 2026
-
A1304 - Endo 1,4-beta-xylanase from Bacillus licheniformis (gene donor: Chryseobacterium cucumeris) for use as a processing aid
FSANZ has assessed an application made by Novonesis to permit the use of the enzyme endo-1,4-beta-xylanase (EC 3.2.1.8) as a processing aid in the production of potable alcohol and starch and gluten fractions, FSANZ has prepared a draft food regulatory measure. FSANZ has provided public notification and welcomes your submission to assist with consideration of the application. ...
Closed 29 January 2026